High expression of NOLC1 as an independent prognostic factor for survival in patients with colorectal cancer

被引:0
作者
Zhiwei Sun
Qianshi Zhang
Jinjuan lv
Yuzhu Sun
Zhen Feng
Mengyan Zhang
Feifan Zhang
Cong Xia
Yina Gao
Zhenyu Zhang
Yun-Fei Zuo
Shuang-Yi Ren
机构
[1] The Second Affiliated Hospital of Dalian Medical University,Department of Gastrointestinal Surgery
[2] Dalian Medical University,Department of Clinical Biochemistry, College of Laboratory Diagnostic Medicine
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Nucleolar and coiled-body phosphoprotein 1 (NOLC1); Colorectal cancer; Pathways enrichment analyses; Prognostic factors; Prognostic biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:15697 / 15712
页数:15
相关论文
共 145 条
[1]  
Alves-Guerra MC(2007)Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival Cancer Res 67 8690-8698
[2]  
Ronchini C(2021)Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 19 329-359
[3]  
Capobianco AJ(2021)PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer Int Immunopharmacol 96 107607-321
[4]  
Benson AB(2021)Phosphorylation regulates cullin-based ubiquitination in tumorigenesis Acta Pharm Sin b 11 309-618
[5]  
Venook AP(2016)Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells Eur J Med Chem 21 611-1705
[6]  
Al-Hawary MM(2020)Exploiting the therapeutic interaction of WNT pathway activation and asparaginase for colorectal cancer therapy Cancer Discov 10 1690-253.e8
[7]  
Arain MA(2018)Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells Cell Mol Biol Lett 27 54-667
[8]  
Chen YJ(2021)Knockdown of NOLC1 inhibits PI3K-AKT pathway to improve the poor prognosis of esophageal carcinoma J Oncol 8 9944132-3534
[9]  
Ciombor KK(2021)Immunomodulatory effects of BRAF, MEK, and CDK4/6 inhibitors: implications for combining targeted therapy and immune checkpoint blockade for the treatment of melanoma Front Immunol 12 661737-151
[10]  
Chen Y(2022)IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment Immunity 55 237-2570